Technical Description
The invention introduces ultra-small, photothermal α-Sn nanoparticles for photothermal cancer therapy.
Problems Addressed
- Harmful Chemicals
- Substrate Degradation
- Complex Therapy
- Poor Photothermal Stability
Tech Features
- Substrate-free Therapy
- Enhanced Particle Stability
- Wavelength Specific Activation
- Improved NIR Absorption
- Biocompatible Materials
Target Audience
- Pharmaceutical Industry
- Diagnostic Centres
- Healthcare
- Cancer Treatment
Tech ID: P35-1943 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
